Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Roche to acquire Flatiron Health
Friday, February 16, 2018Roche and Flatiron Health Inc announced today that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health following on from an existing equity stake of The transaction is expected to close in...
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program
Thursday, February 15, 2018Aurinia Pharmaceuticals Inc a clinical stage biopharmaceutical company focused on the global immunology market today announced that it has launched ALL INTM an educational program for people living with lupus nephritis LN ALL IN is designed to raise...
Bristol-Myers Squibb and Nektar Therapeutics Announce Global Development & Commercialization Collaboration
Thursday, February 15, 2018BristolMyers Squibb Company and Nektar Therapeutics announced the companies have executed a global strategic development and commercialization collaboration for Nektars lead immunooncology program NKTR Under the collaboration the companies will joint...
Vaxart, Inc. Closes Merger with Aviragen Therapeutics, Inc.
Wednesday, February 14, 2018Vaxart Inc announced the completion of its merger with Aviragen Therapeutics Inc In connection with the merger Aviragen Therapeutics Inc changed its name to Vaxart Inc and effected a for reverse split of its common stock The combined company will com...
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Wednesday, February 14, 2018Mallinckrodt plc a leading global specialty pharmaceutical company today announced it has closed the acquisition of Sucampo Pharmaceuticals Inc a global biopharmaceutical company including its commercial and development assets We are pleased to co...
Kadmon Announces Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary Fibrosis
Tuesday, February 13, 2018Kadmon Holdings Inc announced topline results from an ongoing Phase clinical trial evaluating KD its Rhoassociated coiledcoil kinase ROCK inhibitor in patients with idiopathic pulmonary fibrosis IPF who were previously treated with or offered pirfe...
LakePharma Announces Expansion And New MicroBiomanufacturing Center In Hopkinton, MA
Tuesday, February 13, 2018LakePharma Inc the leading USbased biologics company specializing in antibody and protein engineering cell line development and protein production announced today the launch of the LakePharma MicroBiomanufacturing GMP Center in Hopkinton MA Locate...
Teva Announces Launch of a Generic Version of Syprine® in the United States
Monday, February 12, 2018Teva Pharmaceutical Industries Ltd announced the launch of generic version of Syprine trientine hydrochloride capsules mg in the US Trientine hydrochloride is used in the treatment of patients with Wilsons disease who are intolerant of penicillam...
Seattle Genetics and Pieris Pharmaceuticals Announce Multi-Program Immuno-Oncology Collaboration
Monday, February 12, 2018Pieris Pharmaceuticals Inc a clinicalstage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer respiratory and other diseases and Seattle Genetics Inc a global biotechnology company d...
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
Friday, February 09, 2018Acesion Pharma a Danish biotech company developing novel treatments for atrial fibrillation AF the most common cardiac arrhythmia announces today it has received approval to commence its first clinical study for its lead compound AP The phase study...
